Kenta Miki
Yokohama, 2310011, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Real-world outcomes of prostate-specific membrane antigen-targeted radioligand therapy in Japanese patients with metastatic castration-resistant prostate cancer.
Journal: Japanese journal of clinical oncology
Published: September 03, 2025
Prognostic factors of PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
Journal: Prostate cancer and prostatic diseases
Published: June 11, 2025
Comparison of diagnostic performance between manual diagnosis following PROMISE V2 and aPROMISE utilizing Ga/F-PSMA PET/CT.
Journal: Annals of nuclear medicine
Published: April 02, 2025
Bilateral vas deferens suturing to prevent inguinal hernias after radical prostatectomy.
Journal: BJUI compass
Published: February 19, 2025
UPFRONT DOCETAXEL WITH ANDROGEN DEPRIVATION THERAPY IN MALES WITH HIGH-VOLUME METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER: RESULTS OF A SINGLE-INSTITUTION SERIES
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: January 19, 2025
Ten-Year Outcomes of a Phase 3, Multicenter, Randomized Controlled Trial (SHIP0804) With 3-Month Neoadjuvant Androgen Deprivation Prior to 125I-Seed Transperineal Prostate Brachytherapy Followed by Nil Versus 9-Month Adjuvant Hormonal Therapy in Patients With Intermediate-Risk Prostate Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: June 21, 2024
Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessment.
Journal: Translational andrology and urology
Published: May 14, 2024
Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone Acetate.
Journal: JAMA network open
Published: March 15, 2024
Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: November 16, 2023
Effectiveness of Magnetic Resonance Imaging/Ultrasound-guided Target Biopsy in Detecting Clinically Significant Prostate Cancer.
Journal: Anticancer research
Published: November 14, 2023
Correction to: Comparison of outcomes in high‑risk prostate cancer patients treated with low‑/high‑dose‑rate brachytherapy plus external beam radiotherapy.
Journal: International journal of clinical oncology
Published: October 09, 2023
Last Updated: 09/26/2026